Mewburn Ellis LLP

Life Sciences

Partner, Patent Attorney

Chris is proficient in prosecution, opposition and appeal work at the European Patent Office. He also provides associated litigation support in the biotech field, especially biopharmaceuticals, from early stage research through to lifecycle management of approved blockbuster products. Chris has particular experience of large portfolio management, including diverse portfolios arising from large research programmes and those centred about particular products.

Areas of Expertise

Antibodies, especially targeted anti-cancer antibodies. miRNA Novel nucleotides Niche interest in functional foods.

Chris works with a number of overseas clients, including multinational pharmaceutical companies, Japanese food companies and US and Japanese research institutions and biopharma companies of all sizes.

He joined Mewburn Ellis LLP in 1996 before qualifying as a Chartered Patent Attorney in 1999 and later as European Patent Attorney in 2000. He joined the partnership in 2002.

Chris has a degree in neuroscience from the University of Cambridge.